Probio
UEI: GZHYAK6ABHW7
• CAGE: 9BQX1
Overview
Awardee Type
Parent
Company Description
We GenScript ProBio provide end-to-end CDMO service from drug discovery to commercialization in CGT, vaccine, biologics discovery and antibody protein drug with proactive strategies, professional solutions and efficient processes to accelerate drug development for customers.
Name
Probio
Website
Headquarters
Pennington, NJ
United States
United States
Most Recent Award
Nov. 6, 2024
Calculating
Federal contract recipient
PROBIO INC.
(UEI GZHYAK6ABHW7, CAGE 9BQX1)
is headquartered in Pennington NJ.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in September 2021 and
federally registered in
July 2022.
Federal Award Analysis
Probio federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PROBIO INC.
UEI
GZHYAK6ABHW7
CAGE Code
9BQX1
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 16, 2021
Initial Registration
July 7, 2022
Last Registration
April 9, 2025
Registration Activation
April 9, 2025
Registration Expiration
March 28, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
Yes
People
Vendor contacts at Probio
Contract Awards
Probio prime contract awards
Subcontract Awards
Probio subcontract awards
State and Local Awards
Probio state and local contract awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Probio